Results

Total Results: 1,881 records

Showing results for "group".

461. Disposition of Comments for Interventions for the Prevention of Posttraumatic Stress Disorder (PTSD) in Adults After Exposure to Psychological Trauma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_disposition-comments.pdf
     April 02, 2013 - illness) or as a deleterious response to the medication itself (e.g., increased risk of death in group … The group of trauma survivors at highest risk for chronic and debilitating PTSD, as well as complex … Additionally, a significant portion of the group at highest risk will spontaneously lose their diagnosis … Our group recently conducted a comparative effectiveness review of treatment of PTSD and studies in … Executive Summary Also, is there evidence to suggest that findings from studies conducted in one group

462. new disposition of comments insulin analogues -- jda revs.xls (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
     September 01, 2008 - greater HbA1c reduction than patients in the premixed therapy group. … compared to the premixed therapy group with similar rates of hypoglycemia for both treatment groups … compared with 51.3 U in the glargine group. … than in the insulin detemir group (p = 0.001). … Reviriego J, Herz M, Roach P, and the Humalog® Mix25 Spanish Study Group.

463. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - guided by TSAT, but did not change significantly in the group guided by CHr … ; 1 patient in the TSAT group) due to bacterial pneumonia (at week 4 in the CHr group), sudden death … by unknown cause (at week 16 in the CHr group), and liver tumor (at week 7 in the TSAT group). … , but not in the no IV iron (epoetin only) treatment group. … This group consists primarily of manufacturers and device makers.

464. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - The stakeholder group included several topics that were out of the scope of the original review. … Form a stakeholder group representing appropriate clinician, policymakers, and patient perspectives. … American Society of Hypertension (ASH) ASH is the subspecialty group representing generalists and … particular group and to ensure that all participants had an equal opportunity to ask questions and … communication with the stakeholder group.

465. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_executive.pdf
     May 01, 2010 - Estimating between-group differences in disease- specific and overall survival is complex and requires … Estimating between-group differences in disease- specific and overall survival is complex and requires … Estimating between-group differences in disease- specific and overall survival is complex and requires

466. Research Protocol: Clostridium difficile Infection Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
     December 23, 2014 - from C. difficile occurred in persons ≥65 years of age, the 17th leading cause of death in this age group … methods for the risk factor analysis were specified, the study included a clearly defined control group … Technical Experts Technical Experts constitute a multidisciplinary group of clinical, content, and … Is the selection of the comparison group appropriate? … Did attrition result in differences in group characteristics between baseline and followup?

467. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - Form a stakeholder group representing appropriate clinician, policymaker, and patient perspectives. … American College of Physicians The American College of Physicians is the largest group representing … Group discussions were moderated by the Evidence- based Practice Center (EPC) investigators to avoid … communication with the stakeholder group. … The stakeholder group included several topics that were out of scope for the original review.

468. Disposition of Comments Report for Pressure Ulcer Risk Assessment and Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
     May 08, 2013 - many clinicians would consider it unethical to withhold standard care practices from the comparison group … for quality (and included in many quality rating instruments, including the Cochrane Back Review Group … Peer Reviewer #6 Results page 57, line 20...the comparison group had no leg elevation!! … The control group had no heel elevation See response to similar comment by this reviewer. … to the group receiving nutritional supplementation.

469. Phenylketonuria Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
     February 01, 2012 - provide a correlation between Phe level and a measure of executive function • Did not include a control group … Only the RCT,55 however, provides comparative data with a placebo group. … At a dosage of 20 mg/kg/day over 10 weeks, participants in the treatment group increased their Phe … However, response varied substantially within the treatment group, with 33 percent tolerating an increase … The strongest associations are seen in the group for which historical measurements were taken during

470. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
     January 01, 2013 - Slide 1 Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Sensitivity Analysis for Observational Comparative Effectiveness Research This slide set is based on a user guide titled Developing a Protocol for Observati…

471. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - systematic process that involves compiling information on topics and issuing topic drafts to a small group … But hearing decrements were more common in the azithromycin group than in the placebo group. … with 1.83 per patient-year in the placebo group (p=0.01). … Hearing decrements were more common in the azithromycin group than in the placebo group (25% vs. 20% … (ECRI Institute, Applied Solutions Group). Horizon Scanning Structured Comment Form.

472. S149 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s149.pdf
     October 01, 2007 - Choose a treatment group, construct a propensity score for each subject, and categorize subjects into … Estimate the average, over all patients, of the potential outcome for a longitudinal treatment group … Choose an alternate treatment group, say Insulin- Insulin-Insulin, and perform the same series of steps … see an endocrinologist) would have a high probability of transi- tioning from exenatide to another group … These meth- ods have also let us make stable inferences about outcomes for a small treatment group; the

473. GRADING THE STRENGTH OF A BODY OF EVIDENCE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-grading-strength_methods.pdf
     July 01, 2009 - • EPCs will collaborate with the GRADE group to address ongoing challenges in assessing the strength … to the population of interest of another group. … In some systems, such as that of the GRADE working group,4-6 the overall grade for strength of evidence … We recommend that EPCs rate strength of evidence based on a core group of domains that include risk … We thank Gordon Guyatt, Holger Schünemann, and the members of the GRADE working group for their work

474. Revised Protocol - Opioids 12 13 13[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
     December 19, 2013 - This topic was nominated by the National Institutes of Health, which has convened a Working Group to … States Department of Vererans Affairs, The Management of Opioid Therapy for Chronic Pain Working Group … Bombardier C, et al. 2009 updated methods guidelines for systematic reviews in the Cochrane Back Review Group … Key questions were reviewed and refined as needed by the EPC with input from the NIH Working Group and … NIH Working Group In place of Key Informants, a NIH Working Group Planning Meeting occurred to provide

475. antibiotics-respiratory-infection-protocol-140922 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_research-protocol.pdf
     September 22, 2014 - The topic was nominated by a diverse group … We will group together studies that use similar definitions of appropriateness and categorize the different … direct comparative evidence is lacking, we will include before-after studies, with or without a control group … On the other hand, education programs for clinicians may involve small group discussion with a local … Technical Experts Technical Experts comprise a multidisciplinary group of clinical, content, and

476. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - atrial flutter, found no significant difference in AF recurrence at 12 months followup between the group … that had ostial-antral PVI and the group that had ostial-antral PVI with cavotricuspid isthmus ablation … (Three publications from the same group of investigators each reported one death from atrioesophageal … 0.295 (MS as a predictor of AF recurrence in NPAF but not PAF patients) QOL-(FU=12 mo) MS group …  that  had  ostial-­‐ antral  PVI  and  the  group  that  had  ostial-­‐antral

477. Grading_didactic_faculty_approved (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/grading.ppt
     January 01, 2010 - The definitions used by EPC reviewers are different from those used by the GRADE Working Group (as of … In some systems, such as that of the GRADE Working Group, the overall grade for strength of evidence … Reference: Atkins D, Best D, Briss PA, et al, for the GRADE Working Group. … References: Atkins D, Best D, Briss PA, et al, for the GRADE Working Group. … Atkins D, Best D, Briss PA, et al, for the GRADE Working Group.

478. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - for depression among traumatic brain injury patients utilizing psychotropic medications, individual/group … At reassessment, the presence of psychiatric conditions had increased in every group except those never … Of those who completed the study, 59 percent of the treated group and 32 percent of the control group … Of the 11 individuals who dropped out of the study, 6 were in the intended 6-week group and 5 were in … the intended 10-week group.

479. Interventions-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - and 33.7% of comparison group had a MPR greater than or equal to 80%. … compared with SBP in the control group. … (ECRI Institute, Applied Solutions Group). Horizon Scanning Structured Comment Form. … (ECRI Institute, Applied Solutions Group). Horizon Scanning Structured Comment Form. … (ECRI Institute, Applied Solutions Group). Horizon Scanning Structured Comment Form.

480. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - Glucose Tolerance: Fasting glucose increased in the tx group (p<0.05) by month 12 but not in the … control group. … Prospective cohort followed for at least 3 years; no control group Mortality n/a In addition to … Mortality was significantly higher in the control group than in the treated group (13.6 vs. 6.4% … IGFBP-2 and 3 Z- scores were higher in the malignancy group.